Polymyxin B Activity Rescue by (-)-Camphene-Based Thiosemicarbazide Against Carbapenem-Resistant Enterobacterales .
Bruna Renata SilvaPaula Assis QueirozPedro Henrique Rodrigues do AmaralBeatriz Cardoso de FreitasAlison Fernando StoccoEloisa Gibin SampironFábio VandresenMaria Cristina Bronharo TognimKatiany Rizzieri Caleffi-FerracioliRegiane Bertin de Lima ScodroRosilene Fressatti CardosoFelipe de Almeida La PortaVera Lúcia Dias SiqueiraPublished in: Microbial drug resistance (Larchmont, N.Y.) (2022)
Due to the significant shortage of therapeutic options for carbapenem-resistant Enterobacterales (CRE) infections, new drugs or therapeutic combinations are urgently required. We show in this study that (-)-camphene-based thiosemicarbazide (TSC) may act synergistically with polymyxin B (PMB) against CRE, rescuing the activity of this antimicrobial. With the specific aim of a better molecular understanding of this effect caused by the presence of TSC, theoretical calculations were also performed in this study. Based on these findings, it is concluded that the presence of TSC moieties contributes to significant changes in the hydrogen atom charge of PMB structure, which trend more positives for the PMB/TSC system studied. This could lead to the formation of stronger hydrogen bonds in the Enterobacterales active site and, thus contribute to a molecular understanding of the PMB rescue of activity promoted by the presence of TSC moiety. As such, the clinical potential of these drug combinations requires further evaluation.